Involvement of the Renin-Angiotensin System in Stress: State of the Art and Research Perspectives
| Autor: | Marco Antônio Peliky Fontes, Bernardo H M Correa, Luca Becari, Lucas M. Kangussu, Ana Cristina Simões-e-Silva |
|---|---|
| Rok vydání: | 2022 |
| Předmět: |
Canonical system
Angiotensin-Converting Enzyme Inhibitors Stimulation Peptidyl-Dipeptidase A Renin-Angiotensin System Renin–angiotensin system Humans Medicine Endocrine system Pharmacology (medical) Pharmacological modulation Receptor Pharmacology business.industry Angiotensin II Stressor Infant Newborn General Medicine Peptide Fragments Psychiatry and Mental health Neurology Neurology (clinical) Restraint stress business Neuroscience Signal Transduction |
| Zdroj: | Current Neuropharmacology. 20:1212-1228 |
| ISSN: | 1570-159X |
| DOI: | 10.2174/1570159x19666210719142300 |
| Popis: | Along with other canonical systems, the renin-angiotensin system (RAS) has shown essential roles in stress. This system is a complex regulatory proteolytic cascade composed of various enzymes, peptides, and receptors. Besides the classical (ACE/Ang II/AT 1 receptor) and the counter-regulatory (ACE2/Ang-(1-7)/Mas receptor) RAS axes, evidence indicates that non-classical components, including Ang III, Ang IV, AT 2, and AT 4, can also be involved in stress. Objective and methods: This comprehensive review summarizes the current knowledge on the participation of RAS components in different adverse environmental stimuli stressors, including air-jet stress, cage switch stress, restraint stress, chronic unpredictable stress, neonatal isolation stress, and post-traumatic stress disorder. Results and conclusion: In general, activating the classical RAS axis potentiates stress-related cardiovascular, endocrine, and behavioral responses, while the stimulation of the counter-regulatory axis attenuates these effects. Pharmacological modulation in both axes is optimistic, offering promising perspectives for stress-related disorders treatment. In this regard, angiotensin-converting enzyme inhibitors and angiotensin receptor blockers are potential candidates already available because they block the classical axis, activate the counter-regulatory axis, and are safe and efficient drugs. |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|